Back to today’s briefing

Story perspectives

Breakthrough Blood Cells Could Revolutionize Vaccine Efficacy

1/7/2025

39 8

Summary

Story summary

Stanford Medicine researchers have unveiled a groundbreaking link between megakaryocytes—blood cells crucial for clotting—and the longevity of vaccine responses. By pinpointing a unique molecular signature in the blood, they pave the way for personalized vaccines and more effective clinical trials, promising to boost the efficacy of vaccines for influenza and COVID-19.

1 of 1

Story summary

Stanford Medicine researchers have unveiled a groundbreaking link between megakaryocytes—blood cells crucial for clotting—and the longevity of vaccine responses. By pinpointing a unique molecular signature in the blood, they pave the way for personalized vaccines and more effective clinical trials, promising to boost the efficacy of vaccines for influenza and COVID-19.